NCT00143663 - Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol | Biotech Hunter

Enrollment

361

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Dyslipidemia

Interventions

DRUG

Lapaquistat Acetate

Lapaquistat acetate 100 mg, tablets, orally, once daily for up to 12 weeks

DRUG

Placebo

Lapaquistat acetate placebo-matching tablets, orally, once daily for up to 12 weeks

Trial Locations (47)

Unknown

Northport

Mesa

Chula Vista

Encinitas

Long Beach

Pismo Beach

Sacramento

San Diego

Golden

Aventura

Clearwater

Daytona Beach

Hollywood

Jacksonville

Jupiter

New Port Richy

Pembroke Pines

Elk Grove Village

Peoria

Evansville

Indianapolis

Arkansas City

Wichita

Louisville

Livonia

Las Vegas

Margate City

New Hyde Park

Charlotte

Raleigh

Statesville

Wilmington

Winston-Salem

Medford

Downingtown

Sellersville

Tipton

Warwick

Charleston

Mt. Pleasant

Bristol

Dallas

San Antonio

Ogden

Norfolk

Richmond

Madison